Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [●] ("Holder"), as registered owner of this Purchase Warrant, to Tenon Medical, Inc., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time beginning [●], 2022 (the "Commencement Date"), and at or before 5:00 p.m., Eastern time, [●], 2026 (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] shares of common stock of the
...Company, par value $0.00001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context.
View More
Purchase Warrant. THIS CERTIFIES THAT,
for value received by Matthew B. Proman ("Holder") in consideration of
funds duly paid the Merger Agreement dated July 11, 2014 by
or on behalf of [●] ("Holder"), as registered owner of this Purchase Warrant, to Tenon Medical, and among Professional Diversity Network, Inc., a Delaware corporation (the "Company"),
Holder, NAPW, Inc., and NAPW Merger Sub, Inc., Holder is entitled, at any time or from time to time
beginning [●], 2022 from September 24, 2015 (the "Commencement D
...ate"), and at or before 5:00 p.m., Eastern time, [●], 2026 September 24, 2019 (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] 50,000 shares of common stock of the Company, par value $0.00001 $.01 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this the Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $4.00 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context.
View More
Purchase Warrant. THIS CERTIFIES THAT,
in consideration pursuant to that certain Underwriting Agreement by and between Accelerated Pharma, Inc., a Delaware corporation (the "Company"), on one hand, and Rodman & Renshaw, a division of
funds duly paid by H.C. Wainwright & Co., LLC ("Rodman" or
the "Representative"), on
behalf of the other hand, dated [●], 2017 (the "Underwriting Agreement"), [●] ("Holder"), as registered owner of this Purchase Warrant,
to Tenon Medical, Inc., a Delaware corporation (the "Company"),... Holder is entitled, at any time or from time to time beginning from [●], 2022 20[__] (the "Commencement "Exercise Date"), the date that is 360 days after the closing date of the Offering, and at or before 5:00 p.m., Eastern time, on [●], 2026 20221 (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] shares of common stock of the Company, par value $0.00001 per share Common Stock (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] per Share; Share (125% of the price of the Firm Units sold in the Offering); provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price as set forth above or the adjusted exercise price, depending on the context. Capitalized terms not defined herein shall have the meaning ascribed to them in the Underwriting Agreement.
View More
Purchase Warrant. THIS CERTIFIES THAT,
in consideration pursuant to that certain Underwriting Agreement by and between., FOTV Media Networks Inc., a Delaware corporation (the "Company") and Monarch Bay Securities, LLC ("MBS"), as Representative of
funds duly paid by the several underwriters, dated August [●], 2016 (the "Underwriting Agreement"), MBS (in such capacity with its permitted successors or
on behalf of [●] ("Holder"), assigns, the "Holder"), as registered owner of this Purchase Warrant,
to Tenon Medical..., Inc., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time beginning from [●], 2022 2016 (the "Commencement Date"), "Exercise Date") [THE EFFECTIVE DATE OF THE REGISTRATION STATEMENT], and at or before 5:00 p.m., Eastern time, [●], 2026 2021 [DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING] (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] shares [NUMBER OF SHARES EQUAL TO 3% OF SHARES SOLD IN THE IPO] of common stock of the Company, par value $0.00001 $0.001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law or executive order to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period commencing on the date hereof and ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $[10.00] per Share; Share (125.0% of the price of the Shares sold in the Offering); provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context. Any term not defined herein shall have the meaning ascribed thereto in the Underwriting Agreement.
View More
Purchase Warrant. THIS CERTIFIES THAT,
in consideration of funds duly paid by for value received, [·] or
on behalf of [●] its assigns ("Holder"), as registered owner of this Purchase Warrant,
to Tenon Medical, Inc., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], 2022 from [·], 2015 (the "Commencement Date"), and
until at or before 5:00 p.m., Eastern time,
[●], 2026 [·], 2020 (the "Expiration Date"), but not thereafter, to subscribe for, purchase and rec
...eive, in whole or in part, up to [●] [·] shares of common stock of the Company, BioPharmX Corporation, a Delaware corporation (the "Company"), par value $0.00001 $0.001 per share (the "Shares"), subject to adjustment as provided in Section 6 5 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $[·] per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 5 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term "Effective Date" shall mean [·], 2015, the date on which the Registration Statement on Form S-1 (File No. 333-203317) of the Company (the "Registration Statement") was declared effective by the U.S. Securities and Exchange Commission (the "Commission").
View More
Purchase Warrant. THIS CERTIFIES THAT,
pursuant to that certain Underwriting Agreement by and between RVeloCITY Inc., a company incorporated in
consideration the State of
funds duly paid by Delaware (the "Company"), and Boustead Securities, LLC ("Boustead"), dated [●], 2023 (the "Underwriting Agreement"), Boustead (in such capacity with its permitted successors or
on behalf of [●] ("Holder"), assigns, the "Holder"), as registered owner of this Purchase Warrant,
to Tenon Medical, Inc., a Delaware corporation (the ..."Company"), Holder is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time or from time to time beginning from [●], 2022 20__ (the "Commencement Date"), "Exercise Date") [THE DATE THAT THE WARRANT IS ISSUED], and at or before 5:00 p.m., Eastern time, [●], 2026 20__ [DATE THAT IS FIVE YEARS FROM THE DATE ON WHICH THE REGISTRATION STATEMENT IS DECLARED EFFECTIVE] (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] shares of common stock Class A Common Shares of the Company, without par value $0.00001 per share (the "Shares"), subject to adjustment as provided in Section 6 5 hereof. If the Expiration Date is a day on which banking institutions are authorized by law or executive order to close, then this Purchase Warrant may be exercised on the next succeeding day which that is not such a day in accordance with the terms herein. During the period commencing on the date hereof and ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] per Share; Share (the price of the Shares sold in the Offering); provided, however, that upon the occurrence of any of the events specified in Section 6 5 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context. Any term not defined herein shall have the meaning ascribed thereto in the Underwriting Agreement.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] [·] ("Holder"), as registered owner of this Purchase Warrant, to
Tenon Medical, Signal Genetics, Inc., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], 2022 from [·], 20[15] (the "Commencement Date"), and at or before 5:00 p.m., Eastern time,
[●], 2026 [·], 20[19] (the "Expiration
Date"), Date," which date shall not be more than five years from the effective ...date of the registration statement on form S-1 (Registration No. 333-194668) of the Company (the "Registration Statement")), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] [·] shares of common stock of the Company, all warrants will equal an aggregate of 5% of the Shares sold in the Offering, excluding securities sold in the overallotment, par value $0.00001 $0.01 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this the Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $[·] per Share; Share (125% of the price of the Shares sold in the Offering); provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] [*] ("Holder"), as registered owner of this Purchase Warrant, to
Tenon Medical, Jerash Holdings (US), Inc., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], 2022 from [*] [DATE THAT IS 180 DAYS FROM THE CLOSING DATE OF THE OFFERING] (the "Commencement Date"), and at or before 5:00 p.m., Eastern time,
[●], 2026 [DATE THAT IS FIFTH ANNIVERARY OF EFFECTIVE DATE]... (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] shares [*]shares (the "Warrant Shares") of common stock of the Company, par value $0.00001 $0.001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $10.50 per Share; Warrant Share (150% of the price of the shares of common stock sold in the proposed initial public offering of Shares (the "Offering"); provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Warrant Share and the number of Warrant Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term "Effective Date" means [*], 2018, the date that the Company's Registration Statement on Form S-1 (File No: 333-222596) was declared effective under the Securities Act of 1933, as amended (the "Securities Act"), by the U.S. Securities and Exchange Commission (the "Commission").
View More
Purchase Warrant. THIS CERTIFIES THAT,
in consideration for good and valuable consideration, the receipt and sufficiency of
funds duly paid by or on behalf of [●] which is hereby acknowledged, Roth Capital Partners, LLC ("Holder"), as registered owner of this Purchase Warrant,
to Tenon Medical, Inc., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning from [●],
2022 2020 [DATE THAT IS ONE HUNDRED EIGHTY (180) DAYS FROM THE EFFECTIVE DATE OF THE OFFERING] (the "Co
...mmencement Date"), and at or before 5:00 p.m., Eastern time, [●], 2026 2025 [DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING] (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] shares [ ] (the "Shares") of common stock of the Company, stock, par value $0.00001 $0.0001 per share (the "Shares"), "Common Stock"), of Myomo, Inc., a Delaware corporation (the "Company"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized or required by law or executive order to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] per Share; Share [equal to the price of the shares sold in the Offering]; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. This Purchase Warrant is being issued in connection with a public offering of shares of Common Stock pursuant to the Company's registration statement on Form S-1 (File No. : 333- ) (the "Offering"). The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context. As used herein, "Effective Date" means the date on which the Shares being sold in the Offering first become legally eligible for distribution to the public as determined in accordance with FINRA Conduct Rule 5110(a)(12).
View More
Purchase Warrant. THIS
CERTIFIES THAT, in consideration COMMON STOCK PURCHASE WARRANT (this "Purchase Warrant") certifies that, pursuant to that certain Underwriting Agreement by and between Fortune Valley Treasures, Inc., a State of
funds duly paid by Nevada company (the "Company") and Joseph Stone Capital, LLC ("Joseph Stone"), dated [ ● ], 2022 (the "Underwriting Agreement"), [ ] (in such capacity with its permitted successors or
on behalf of [●] ("Holder"), assigns, the "Holder"), as registered owner of this
...Purchase Warrant, to Tenon Medical, Inc., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time beginning [●], from [ ● ], 2022 (the "Commencement Date"), "Exercise Date") [THE DATE THAT IS 180 DAYS AFTER THE EFFECTIVE DATE], and at or before 5:00 p.m., Eastern time, [●], 2026 [ ● ], 2027 [THE DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE] (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] shares of common stock Common Stock of the Company, par value $0.00001 $0.001 per share (the "Shares"), subject to adjustment as provided in Section 6 5 hereof. If the Expiration Date is a day on which banking institutions are authorized by law or executive order to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period commencing on the date hereof and ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $[ ● ] per Share; Share (125% of the price of the Shares sold in the Offering); provided, however, that upon the occurrence of any of the events specified in Section 6 5 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context. Any term not defined herein shall have the meaning ascribed thereto in the Underwriting Agreement.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] [*] ("Holder"), as registered owner of this Purchase Warrant, to
Tenon Medical, Jerash Holdings (US), Inc., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], 2022 from [*] [DATE THAT IS 180 DAYS FROM THE CLOSING DATE OF THE OFFERING] (the "Commencement Date"), and at or before 5:00 p.m., Eastern time,
[●], 2026 [DATE THAT IS FIFTH ANNIVERSARY OF EFFECTIVE DATE...] (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] shares [*]shares (the "Warrant Shares") of common stock of the Company, par value $0.00001 $0.001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $8.75 per Share; Warrant Share (125% of the price of the shares of common stock sold in the proposed initial public offering of Shares (the "Offering"); provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Warrant Share and the number of Warrant Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term "Effective Date" means [*], 2018, the date that the Company's Registration Statement on Form S-1 (File No: 333-222596) was declared effective under the Securities Act of 1933, as amended (the "Securities Act"), by the U.S. Securities and Exchange Commission (the "Commission").
View More
